The widespread use of antiretroviral therapy has prolonged the survival of people living with HIV (PLWH). Among these patients, co-existing cardiovascular diseases, particularly left ventricular diastolic dysfunction (LVDD), are receiving increasing attention.
Methods
We recruited 386 patients in the PLWH group and 386 sex- and age (± 3 years)-matched individuals in the HIV-negative group, and used logistic regression to determine the risk factors of LVDD.
Results
Compared to the HIV-negative group, PLWH had a significantly higher prevalence of smoking (p < .001), alcohol consumption (p < .001), hypertension (p = .002), diabetes (p = .020), and hyperlipidemia (p < .001) and a lower prevalence of body mass index (BMI) ≥ 24.0 kg/m2 (p < .001). The prevalence of LVDD on echocardiography was significantly higher in PLWH than in the HIV-negative group (25.9% vs 16.1%, p = .001). The multivariate analysis showed that non-youth (OR = 8.666; 95%CI = 4.310-17.459; p < .001), BMI ≥ 24.0 kg/m2 (OR = 1.992; 95% CI = 1.007-3.939; p = .048), hypertension (OR = 1.888; 95% CI = 1.044-3.415; p = .036), hyperlipidemia (OR = 1.911; 95% CI = 1.068-3.418; p = .029), and HIV infection (OR = 2.003; 95%CI = 1.341-2.992; p = .001) were risk factors for LVDD.
Conclusion
The rate of echocardiographic abnormalities was higher in PLWH. LVDD was associated with non-youth, BMI ≥ 24.0 kg/m2, hypertension, hyperlipidemia, and living with HIV.
ChangDEsberADearN, et al.Non-communicable diseases in older people living with HIV in four African countries: a cohort study. The Lancet HIV2022; 9: S5. DOI: 10.1016/S2352-3018(22)00070-4.
2.
SmitMBrinkmanKGeerlingsS, et al.Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis2015; 15(7): 810–818. DOI: 10.1016/S1473-3099(15)00056-0.
3.
AchwokaDWaruruAChenTH, et al.Noncommunicable disease burden among HIV patients in care: a national retrospective longitudinal analysis of HIV-treatment outcomes in Kenya, 2003-2013. BMC Publ Health2019; 19(1): 372. DOI: 10.1186/s12889-019-6716-2.
4.
ChezaATlouBZhouDT. Incidence of non-communicable diseases (NCDs) in HIV patients on ART in a developing country: case of Zimbabwe’s Chitungwiza Central Hospital—A retrospective cohort study (2010–2019). PLoS One2021; 16(5): e0252180. DOI: 10.1371/journal.pone.0252180.
5.
van HeerdenABarnabasRVNorrisSA, et al.High prevalence of HIV and non‐communicable disease (NCD) risk factors in rural KwaZulu‐Natal, South Africa. J Int AIDS Soc2017; 20(2): e25012. DOI: 10.1002/jia2.25012.
6.
ShahASVStelzleDLeeKK, et al.Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation2018; 138(11): 1100–1112. DOI: 10.1161/CIRCULATIONAHA.117.033369.
7.
LiuXSunYZhanY, et al.Prevalence and risk of subclinical carotid atherosclerosis in the global population with HIV: a systematic review and meta-analysis. Int J STD AIDS2021; 32(5): 411–420. DOI: 10.1177/0956462420972854.
8.
DorjeeKDesaiMChodenT, et al.Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States. AIDS Res Ther2021; 18(1): 57. DOI: 10.1186/s12981-021-00383-7.
9.
AlviRMNeilanAMTariqN, et al.Protease inhibitors and cardiovascular outcomes in patients with HIV and heart failure. J Am Coll Cardiol2018; 72(5): 518–530. DOI: 10.1016/j.jacc.2018.04.083.
10.
OgunmodedeJAKoloPMKatibiIA, et al.Structural echocardiographic abnormalities seen in HIV/AIDS patients are independent of cd4 count. Niger J Clin Pract2017; 20(6): 716–723. DOI: 10.4103/1119-3077.208954.
11.
MajongaEDRehmanAMSimmsV, et al.High prevalence of echocardiographic abnormalities in older HIV-infected children taking antiretroviral therapy. AIDS (London, England)2018; 32(18): 2739–2748. DOI: 10.1097/QAD.0000000000002031.
12.
Doria de VasconcellosHPostWSErvinAM, et al.Associations between HIV serostatus and cardiac structure and function evaluated by 2‐dimensional echocardiography in the Multicenter AIDS Cohort Study. J Am Heart Assoc2021; 10(7): e019709. DOI: 10.1161/JAHA.120.019709.
13.
MahtabSLawrensonJJamieson-LuffN, et al.Echocardiographic findings in a cohort of perinatally HIV-infected adolescents compared with uninfected peers from the Cape Town adolescent antiretroviral cohort. J Am Soc Echocardiog2020; 33(5): 604–611. DOI: 10.1016/j.echo.2019.12.010.
14.
SudKArgulianE. Echocardiography in patients with HIV infection. Curr Cardiol Rep2020; 22(9): 100. DOI: 10.1007/s11886-020-01347-5.
15.
LaurenceJElhadadSRobisonT, et al.HIV protease inhibitor-induced cardiac dysfunction and fibrosis is mediated by platelet-derived TGF-β1 and can be suppressed by exogenous carbon monoxide. PLoS One2017; 12(10): e0187185. DOI: 10.1371/journal.pone.0187185.
16.
ButlerJGreeneSJShahSH, et al.Diastolic dysfunction in patients with human immunodeficiency virus receiving antiretroviral therapy: results from the CHART study. J Card Fail2020; 26(5): 371–380. DOI: 10.1016/j.cardfail.2019.10.011.
17.
NaguehSFSmisethOAAppletonCP, et al.Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiog2016; 29: 277–314. DOI: 10.1016/j.echo.2016.01.011.
18.
WangRVetranoDLLiangY, et al.The age-related blood pressure trajectories from young-old adults to centenarians: a cohort study. Int J Cardiol2019; 296: 141–148. DOI: 10.1016/j.ijcard.2019.08.011.
19.
WheltonPKCareyRMAronowWS, et al.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol2018; 71(19): e127–e248. DOI: 10.1016/j.jacc.2017.11.006.
20.
AlbertiKGZimmetPZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med1998; 15(7): 539–553. DOI: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.
21.
National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of high blood cholesterol in adults (Adult treatment panel). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high cholesterol in adults (Adult Treatment Panel III). Circulation2002; 106: 3143–3421.
22.
ZhouBF. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases--report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci2002; 15(3): 245–252.
23.
JohnstonPIWrightSWOrrM, et al.Worldwide relative smoking prevalence among people living with and without HIV. AIDS2021; 35(6): 957–970. DOI: 10.1097/QAD.0000000000002815.
24.
WürtzPCookSWangQ, et al.Metabolic profiling of alcohol consumption in 9778 young adults. Int J Epidemiol2016; 45(5): 1493–1506. DOI: 10.1093/ije/dyw175.
25.
Míguez-BurbanoMJQuirosCLewisJE, et al.Gender differences in the association of hazardous alcohol use with hypertension in an urban cohort of people living with HIV in South Florida. PLoS One2014; 9(12): e113122. DOI: 10.1371/journal.pone.0113122.
26.
PetoumenosKLawMG. Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons. Curr Opin HIV AIDS2016; 11(5): 514–520. DOI: 10.1097/COH.0000000000000306.
27.
MusekwaRHamooyaBMKoetheJR, et al.Prevalence and correlates of hypertension in HIV-positive adults from the Livingstone Central Hospital, Zambia. Pan Afr Med J2021; 39(1): 237. DOI: 10.11604/pamj.2021.39.237.29718.
28.
RoozenGVTMeelRPeperJ, et al.Electrocardiographic and echocardiographic abnormalities in urban African people living with HIV in South Africa. PLoS One2021; 16(2): e0244742. DOI: 10.1371/journal.pone.0244742.
29.
MulugetaHAfenigusADHaileD, et al.Incidence and predictors of hypertension among HIV patients receiving ART at public health facilities, northwest Ethiopia: A one-year multicenter prospective follow-up study. HIV AIDS (Auckl)2021; 13: 889–901. DOI: 10.2147/HIV.S329838.
30.
KagarukiGBMayigeMTNgadayaES, et al.Magnitude and risk factors of non-communicable diseases among people living with HIV in Tanzania: a cross sectional study from Mbeya and Dar es Salaam regions. BMC Publ Health2014; 14(1): 904. DOI: 10.1186/1471-2458-14-904.
31.
FisehaTBeleteAGDerejeH, et al.Hypertension in HIV-infected patients receiving antiretroviral therapy in Northeast Ethiopia. Int J Hypertens2019; 2019: 4103604–4103604. DOI: 10.1155/2019/4103604.
32.
TiozzoERodriguezAKonefalJ, et al.The relationship between HIV duration, insulin resistance and diabetes risk. Int J Environ Res Publ Health2021; 18(8): 3926. DOI: 10.3390/ijerph18083926.
33.
LeoneSLorenziniPCozzi-LepriA, et al.Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study. Eur J Clin Microbiol Infect Dis2019; 38: 1857–1865. DOI: 10.1007/s10096-019-03618-8.
34.
IqbalSSalmanSAkhtarM, et al.Spectrum of Dyslipidemias in Treatment-Naïve Human Immunodeficiency Virus-Infected Patients Presenting to an HIV Clinic of a Tertiary Care Hospital. Cureus2022; 14: e21972. DOI: 10.7759/cureus.21972.
35.
NsaghaDSWeledjiEPAssobNJ, et al.Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon. BMC Cardiovasc Disord2015; 15: 95. DOI: 10.1186/s12872-015-0090-5.
36.
LuetkensJADoernerJSchwarze-ZanderC, et al.Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients. Circ Cardiovasc Imag2016; 9(3): e004091. DOI: 10.1161/CIRCIMAGING.115.004091.
37.
LuoLZengYLiT, et al.Prospective echocardiographic assessment of cardiac structure and function in Chinese persons living with HIV. Clin Infect Dis2014; 58(10): 1459–1466. DOI: 10.1093/cid/ciu086.
38.
CerratoED'AscenzoFBiondi-ZoccaiG, et al.Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. Eur Heart J2013; 34(19): 1432–1436. DOI: 10.1093/eurheartj/ehs471.
39.
Fontes-CarvalhoRMancioJMarcosA, et al.HIV patients have impaired diastolic function that is not aggravated by anti-retroviral treatment. Cardiovasc Drugs Ther2015; 29: 31–39. DOI: 10.1007/s10557-015-6573-x.
40.
ToribioMNeilanTGZanniMV. Heart failure among people with HIV: evolving risks, mechanisms, and preventive considerations. Curr HIV AIDS Rep2019; 16: 371–380. DOI: 10.1007/s11904-019-00458-1.
41.
OlivieroUBonadiesGBossoG, et al.Impaired diastolic function in naïve untreated human immunodeficiency virus infected patients. World J Cardiol2010; 2(4): 98–103. DOI: 10.4330/wjc.v2.i4.98.
42.
ButlerJKalogeropoulosAPAnstromKJ, et al.Diastolic dysfunction in individuals with human immunodeficiency virus infection: literature review, rationale and design of the characterizing heart function on antiretroviral therapy (CHART) study. J Card Fail2018; 24(4): 255–265. DOI: 10.1016/j.cardfail.2018.02.001.
